These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18438836)

  • 1. Calcium signaling in systemic lupus erythematosus lymphocytes and its therapeutic exploitation.
    Tsokos GC
    Arthritis Rheum; 2008 May; 58(5):1216-9. PubMed ID: 18438836
    [No Abstract]   [Full Text] [Related]  

  • 2. Manidipine hydrochloride-induced chyloperitoneum in a patient with systemic lupus erythematosus.
    Tanabe M; Iwata H; Kinoshita M; Sumiya M; Saima S
    Clin Nephrol; 1999 Mar; 51(3):195-6. PubMed ID: 10099897
    [No Abstract]   [Full Text] [Related]  

  • 3. Vitamin D in systemic lupus erythematosus.
    Kamen D; Aranow C
    Curr Opin Rheumatol; 2008 Sep; 20(5):532-7. PubMed ID: 18698173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced lupus erythematosus.
    Vedove CD; Del Giglio M; Schena D; Girolomoni G
    Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered B-cell signaling in lupus.
    Liu K; Mohan C
    Autoimmun Rev; 2009 Jan; 8(3):214-8. PubMed ID: 18722559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered T and B lymphocyte signaling pathways in lupus.
    Peng SL
    Autoimmun Rev; 2009 Jan; 8(3):179-83. PubMed ID: 18721908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prasterone and bone mineral density in women with systemic lupus erythematosus.
    Alexander T; Friel PN; Wright JV
    J Rheumatol; 2005 Dec; 32(12):2497; author reply 2497-8. PubMed ID: 16331796
    [No Abstract]   [Full Text] [Related]  

  • 8. The type I interferon system in systemic lupus erythematosus.
    Rönnblom L; Eloranta ML; Alm GV
    Arthritis Rheum; 2006 Feb; 54(2):408-20. PubMed ID: 16447217
    [No Abstract]   [Full Text] [Related]  

  • 9. [Disseminated lupus erythematosus: new pathophysiological and therapeutic approaches].
    Haddad E
    Arch Pediatr; 2004 Jun; 11(6):512-4. PubMed ID: 15158814
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoimmune diseases and fungal infections: immunological mechanisms and therapeutic approaches.
    Zhang JZ
    Chin Med J (Engl); 2009 Mar; 122(5):483-5. PubMed ID: 19323895
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment with testosterone or estradiol in melatonin treated females and males MRL/MpJ-Faslpr mice induces negative effects in developing systemic lupus erythematosus.
    Jimenez-Caliani AJ; Jimenez-Jorge S; Molinero P; Rubio A; Guerrero JM; Osuna C
    J Pineal Res; 2008 Sep; 45(2):204-11. PubMed ID: 18507713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New immune modulatory drugs for systemic lupus erythematosus--what can we expect?
    Davidson A
    Nat Clin Pract Rheumatol; 2006 Dec; 2(12):638-9. PubMed ID: 17133245
    [No Abstract]   [Full Text] [Related]  

  • 13. Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus.
    Pan HF; Ye DQ; Li XP
    Nat Clin Pract Rheumatol; 2008 Jul; 4(7):352-3. PubMed ID: 18477998
    [No Abstract]   [Full Text] [Related]  

  • 14. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
    Kumar S; Benseler SM; Kirby-Allen M; Silverman ED
    Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of inactive X chromosome: a potential culprit and therapeutic target for systemic lupus erythematosus.
    Pan HF; Ye DQ; Li XP
    Med Hypotheses; 2008; 70(6):1231-2. PubMed ID: 18262729
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunologic evaluation of the treatment of systemic lupus erythematosus].
    Ohashi M
    Nihon Hifuka Gakkai Zasshi; 1977 Nov; 87(12):785-7. PubMed ID: 304926
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostaglandin E2-mediated dysregulation of proinflammatory cytokine production in pristane-induced lupus mice.
    Chae BS; Shin TY; Kim DK; Eun JS; Leem JY; Yang JH
    Arch Pharm Res; 2008 Apr; 31(4):503-10. PubMed ID: 18449509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
    Yao Y; Richman L; Higgs BW; Morehouse CA; de los Reyes M; Brohawn P; Zhang J; White B; Coyle AJ; Kiener PA; Jallal B
    Arthritis Rheum; 2009 Jun; 60(6):1785-96. PubMed ID: 19479852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation in T cells from idiopathic lupus and drug-induced lupus patients.
    Zhou Y; Lu Q
    Autoimmun Rev; 2008 May; 7(5):376-83. PubMed ID: 18486925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A possible role of Fas-ligand-mediated "reverse signaling" in pathogenesis of rheumatoid arthritis and systemic lupus erythematosus.
    Telegina E; Reshetnyak T; Moshnikova A; Proussakova O; Zhukova A; Kuznetsova A; Ivanov A; Paltsev M; Beletsky I
    Immunol Lett; 2009 Jan; 122(1):12-7. PubMed ID: 19010354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.